Authors

• Lawrence K. Fox (ORCID: https://orcid.org/0000-0001-7659-7809)
• Michael J. Stirratt (ORCID: https://orcid.org/0000-0001-5243-9312)
• Sara B. Sieczkarski
• JE Lake
• Kati Vandermeulen
• Kristina M. Brooks (ORCID: https://orcid.org/0000-0002-3832-8699)
• Kathie G. Ferbas (ORCID: https://orcid.org/0009-0005-8861-2240)
• S. S. Heath
• Cheryl Jennings (ORCID: https://orcid.org/0009-0002-3508-5350)
• E P Acosta
• Steven Shoptaw
• Charles S. Venuto
• Jose R. Castillo-Mancilla
• Chanelle Wimbish
• Paul Wannamaker
• Ronald D’Amico
• Tia Morton
• Omar Galáarraga
• Jonathan Z. Li
• Madison Green
• Aadia I. Rana
• Raphael J. Landovitz
• Ceora Beijer
• Pablo F. Belaunzaran-Zamudio
• Romina Collahua
• David Wohl
• Karen T. Tashima
• Kimberly Smith
• Rodica Van Solingen-Ristea
• Carl Fichtenbaum
• William Spreen
• Michael Dorosh

Institutions

• University of North Carolina at Chapel Hill (US)
• Brigham and Women's Hospital (US)
• Rush University Medical Center (US)
• National Institutes of Health (US)
• Harvard University (US)
• University of California, Los Angeles (US)
• Brown University (US)
• University of Alabama at Birmingham (US)
• The Coordinating Center (US)
• National Institute of Allergy and Infectious Diseases (US)
• Frontier Science & Technology Research Foundation, Inc. (US)
• Office of AIDS Research (US)
• University of Colorado Anschutz Medical Campus (US)
• University of Rochester (US)
• The University of Texas Health Science Center at Houston (US)
• University of Cincinnati Medical Center (US)

Publication Details

Journal

New England Journal of Medicine

Published

2026-02-18

DOI

https://doi.org/10.1056/nejmoa2508228

Citations

2

Primary Topic

HIV/AIDS drug development and treatment

Type

article

Field-Weighted Citation Impact

65.56